1. Home
  2. XELB vs CLRB Comparison

XELB vs CLRB Comparison

Compare XELB & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$2.07

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.47

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
CLRB
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.0M
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
XELB
CLRB
Price
$2.07
$2.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$10.00
AVG Volume (30 Days)
102.6K
178.1K
Earning Date
04-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$102.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.29
52 Week High
$2.66
$10.19

Technical Indicators

Market Signals
Indicator
XELB
CLRB
Relative Strength Index (RSI) 50.58 42.13
Support Level $2.00 N/A
Resistance Level $2.33 $3.40
Average True Range (ATR) 0.22 0.20
MACD -0.01 -0.03
Stochastic Oscillator 62.49 28.16

Price Performance

Historical Comparison
XELB
CLRB

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: